137 related articles for article (PubMed ID: 11801752)
21. Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer.
Masuda N; Fukuoka M; Kudoh S; Kusunoki Y; Matsui K; Nakagawa K; Hirashima T; Tamanoi M; Nitta T; Yana T
J Clin Oncol; 1994 Jan; 12(1):90-6. PubMed ID: 7505810
[TBL] [Abstract][Full Text] [Related]
22. A phase II study of a three-drug combination (cisplatin, ifosfamide and vinorelbine) plus granulocyte-colony stimulating factor in advanced non small cell lung cancer.
Tognoni A; Cadenotti L; Pensa F; Vaira F; Vigani A; Bancalari L; Cordani S; Maggiani R; Canessa PA; Pronzato P
J Chemother; 1999 Aug; 11(4):306-9. PubMed ID: 10465134
[TBL] [Abstract][Full Text] [Related]
23. Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06.
Komaki R; Scott C; Lee JS; Urtasun RC; Byhardt RW; Emami B; Andras EJ; Asbell SO; Rotman M; Cox JD
Am J Clin Oncol; 1997 Oct; 20(5):435-40. PubMed ID: 9345325
[TBL] [Abstract][Full Text] [Related]
24. Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study.
Frasci G; Comella P; Thomas R; Di Bonito M; Lapenta L; Capasso I; Botti G; Vallone P; De Rosa V; D'Aiuto G; Comella G
Cancer Chemother Pharmacol; 2004 Jan; 53(1):25-32. PubMed ID: 14513281
[TBL] [Abstract][Full Text] [Related]
25. Vinblastine, ifosfamide, gallium nitrate, and filgrastim in platinum- and paclitaxel-resistant ovarian cancer: a phase II study.
Dreicer R; Lallas TA; Joyce JK; Anderson B; Sorosky JI; Buller RE
Am J Clin Oncol; 1998 Jun; 21(3):287-90. PubMed ID: 9626800
[TBL] [Abstract][Full Text] [Related]
26. A study of filgrastim (rG-CSF) priming of etoposide/cisplatin in advanced non-small cell lung cancer.
Mehdi SA; Perry MC; Herndon JE; Crawford J; Young R; Graziano SL
J Interferon Cytokine Res; 1998 Aug; 18(8):623-7. PubMed ID: 9726444
[TBL] [Abstract][Full Text] [Related]
27. A phase II trial of carboplatin/vinorelbine with pegfilgrastim support for the treatment of patients with advanced non-small cell lung cancer.
Riedel RF; Andrews C; Garst J; Dunphy F; Herndon JE; Blackwell S; Barbour S; Crawford J
J Thorac Oncol; 2007 Jun; 2(6):520-5. PubMed ID: 17545847
[TBL] [Abstract][Full Text] [Related]
28. Combination chemotherapy with vinorelbine, ifosfamide, and cisplatin: a phase II study in stage IIIB-IV non-small cell lung cancer.
Baldini E; Tibaldi C; Chella A; Angeletti CA; Romanini A; Andrei A; Algeri R; Silvano G; Conte PF
Semin Oncol; 1994 Jun; 21(3 Suppl 4):12-5. PubMed ID: 8209271
[TBL] [Abstract][Full Text] [Related]
29. Phase I study of paclitaxel and etoposide for metastatic or recurrent malignancies.
Lilenbaum RC; MacManus D; Engstrom C; Green M
Am J Clin Oncol; 1998 Apr; 21(2):129-34. PubMed ID: 9537196
[TBL] [Abstract][Full Text] [Related]
30. Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer.
Khuri FR; Rigas JR; Figlin RA; Gralla RJ; Shin DM; Munden R; Fox N; Huyghe MR; Kean Y; Reich SD; Hong WK
J Clin Oncol; 2001 May; 19(10):2626-37. PubMed ID: 11352954
[TBL] [Abstract][Full Text] [Related]
31. First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: a multicenter phase II study.
Georgoulias V; Androulakis N; Dimopoulos AM; Kourousis C; Kakolyris S; Papadakis E; Apostolopoulou F; Papadimitriou C; Vossos A; Agelidou M; Heras P; Tzannes S; Vlachonicolis J; Mavromanolakis E; Hatzidaki D
Ann Oncol; 1998 Mar; 9(3):331-4. PubMed ID: 9602269
[TBL] [Abstract][Full Text] [Related]
32. Induction chemotherapy with and without recombinant human granulocyte colony-stimulating factor support in locally advanced stage IIIA/B non-small cell lung cancer.
Fischer JR; Manegold C; Bülzebruck H; Vogt-Moykopf I; Drings P
Semin Oncol; 1994 Jun; 21(3 Suppl 4):20-7. PubMed ID: 7516094
[TBL] [Abstract][Full Text] [Related]
33. Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients.
Shapiro CL; Ayash L; Webb IJ; Gelman R; Keating J; Williams L; Demetri G; Clark P; Elias A; Duggan D; Hayes D; Hurd D; Henderson IC
J Clin Oncol; 1997 Feb; 15(2):674-83. PubMed ID: 9053493
[TBL] [Abstract][Full Text] [Related]
34. Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer.
Masuda N; Fukuoka M; Kudoh S; Matsui K; Kusunoki Y; Takada M; Nakagawa K; Hirashima T; Tsukada H; Yana T
J Clin Oncol; 1994 Sep; 12(9):1833-41. PubMed ID: 7521905
[TBL] [Abstract][Full Text] [Related]
35. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
Langer CJ; Movsas B; Hudes R; Schol J; Keenan E; Kilpatrick D; Yeung C; Curran W
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
[TBL] [Abstract][Full Text] [Related]
36. Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303).
Miller AA; Wang XF; Gu L; Hoffman P; Khatri J; Dunphy F; Edelman MJ; Bolger M; Vokes EE; Green MR;
J Thorac Oncol; 2008 Oct; 3(10):1159-65. PubMed ID: 18827613
[TBL] [Abstract][Full Text] [Related]
37. Integration of filgrastim into chemoradiation for limited small cell lung cancer: a Phase I study.
Glisson B; Komaki R; Lee JS; Shin DM; Fossella F; Murphy WK; Kurie J; Perez-Soler R; Schea R; Vadhan-Raj S
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):331-6. PubMed ID: 9457817
[TBL] [Abstract][Full Text] [Related]
38. Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.
Langer CJ; Leighton JC; Comis RL; O'Dwyer PJ; McAleer CA; Bonjo CA; Engstrom PF; Litwin S; Ozols RF
J Clin Oncol; 1995 Aug; 13(8):1860-70. PubMed ID: 7543559
[TBL] [Abstract][Full Text] [Related]
39. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.
Lena MD; Ramlau R; Hansen O; Lorusso V; Wagner L; Barni S; Cristovao MM; Huber R; Alberola V; Mitrovic M; Colin C; Gasmi J
Lung Cancer; 2005 Apr; 48(1):129-35. PubMed ID: 15777980
[TBL] [Abstract][Full Text] [Related]
40. Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer.
Lee JS; Libshitz HI; Fossella FV; Murphy WK; Pang AC; Lippman SM; Shin DM; Dimery IW; Glisson BS; Hong WK
Cancer; 1991 Sep; 68(5):959-64. PubMed ID: 1655220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
